Darunavir
规格
206361-99-1CAS 号
606-590-1EC 号
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamateIUPAC 名称
C27H37N3O7S化学式
547.7 g/mol分子量
Darunavir; 206361-99-1; TMC114; TMC-114; UIC-94017; Darunavirum; TMC 114; (-)-DARUNAVIR; DTXSID0046779; UIC 94017; CHEBI:367163; TMC-41629; YO603Y8113; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; DTXCID8026779; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; ((1S,2R)-3-((4-Amino-benzenesulfonyl)-isobutyl-amino)-1-benzyl-2-hydroxy-propyl)-carbamic acid (3R,3aS,6aR)-(hexahydro-furo(2,3-b)furan-3-yl) ester; ((3R,3aS,6aR)-2,3,3a,4,5,6a-hexahydrofuro(5,4-b)furan-3-yl) N-((2S,3R)-4-((4-aminophenyl)sulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)carbamate; ((S)-3-((4-Amino-benzenesulfonyl)-isobutyl-amino)-2-hydroxy-1-((R)-phenylmethyl)-propyl)-carbamic acid (3R,3aS,6aR)-(hexahydro-furo(2,3-b)furan-3-yl) ester; (3R,3aS,6aR)-hexahydrofuro(2,3-b)furan-3-yl N-((2S,3R)-3-hydroxy-4-(N-(2-methylpropyl)(4-aminobenzene)sulfonamido)-1-phenylbutan-2-yl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo(2,3-b)furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo(2,3-b)furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; [(3R,3aS,6aR)-2,3,3a,4,5,6a-hexahydrofuro[5,4-b]furan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; Ethanolate, Darunavir; RefChem:585195; (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; J05AE10; 114, TMC; UIC94017; Prezista; Darunavirum [INN-Latin]; Derunavir; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; MFCD09260006; CHEMBL1323; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; C27H37N3O7S; (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamate; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; Darunavir [USAN]; NCGC00168773-01; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; DRV; Prezista(TM); Darunavir [INN]; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; AIDS073035; Darunavir (USAN/INN); Darunavir [USAN:INN:BAN]; Prezista Naive; Darunavir?; UNII-YO603Y8113; HSDB 7788; 2idw; 2ien; 3bvb; 3cyw; 3ekt; 3ggu; 3lzs; 3lzu; 3lzv; 3ogp; 3pwm; 3qoz; 3tkw; 3ttp; 4hla; Darunavir (DRV); (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ((2S,3R)-4-((4-AMINO-N-ISOBUTYLPHENYL)SULFONAMIDO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)CARBAMATE; TMC41629; TMC 41629; UIC-96017; 2f8g; 2hs1; 2hs2; 3d1z; 3so9; 3t3c; 3u7s; 4ll3; DARUNAVIR [MI]; DARUNAVIR [HSDB]; DARUNAVIR [VANDF]; DARUNAVIR [MART.]; DRV & AAG; DRV & HSA; Epitope ID:231714; DARUNAVIR [WHO-DD]; DARUNAVIR [EMA EPAR]; SCHEMBL118546; BDBM8125; orb1225723; orb1305688; UIC-940T; DARUNAVIR [ORANGE BOOK]; Darunavir, >=98% (HPLC); GTPL11243; 2f80; 2f81; 3d20; 3s53; 3s54; CJBJHOAVZSMMDJ-HEXNFIEUSA-N; GLXC-05003; HMS3715I13; EX-A4009; IVB37837; Tox21_112634; US10806794, Compound Darunavir; Darunavir & alpha1-acid glycoprotein; EBC-27304; MSK169308; s5250; AKOS015966592; CCG-269991; CS-0749; DB01264; FH20801; KS-1469; NCGC00388284-07; NCGC00388284-08; NCGC00388284-10; NCGC00388284-12; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; AC-26778; HY-17040; CAS-206361-99-1; NS00000472; D03656; AB01565837_02; D022705; EN300-20600172; F547231; Q3765251; BRD-K84986517-001-01-8; Z2301684748; ((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-carbamic acid (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester; ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-CARBAMIC ACID (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ESTER; (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(ISOBUTYL)AMINO)-1-BENZYL-2-HYDROXYPROPYL)CARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(sup 1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[4-amino-N-(2-methylpropyl)benzene-1-sulfonamido]-3-hydroxy-1-phenylbutan-2-yl}carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester; Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester同义词
含有Darunavir的产品
PREZISTA 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULAPREZISTA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULADARUNAVIR VIVANTA 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR VIVANTA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAS EFGDARUNAVIR TARBIS 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR TARBIS 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR TARBIS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR MYLAN 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR MYLAN 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR KRKA 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDARUNAVIR KRKA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
第 1/4 页
销售Darunavir的公司
HR
Hangzhou Royall Import & Export Co.,LtdChinaSI
Sinoway Industrial Co.Ltd.ChinaAI
A.H.A International Co., Ltd.SF
Sandoz Farmaceutica S.A.SpainSA
SANDOZFrance第 1/3 页